SMTL ID : 6fgb.1

Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 2 residues within 4Å: Chain A: N.55, Q.56 Ligand excluded by PLIP CL.3: 3 residues within 4Å: Chain C: K.44, K.47, A.48 Ligand excluded by PLIP

2 x NA: SODIUM ION(Non-functional Binders)

NA.2: 2 residues within 4Å: Chain A: F.110, E.151 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.151 NA.4: 6 residues within 4Å: Chain A: K.109, E.116 Chain D: N.31, G.33, S.53, I.100 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:G.33, D:S.53, D:S.53

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Smith, B. et al., Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs (2018)

Release Date

2018-08-29

Peptides

IgG receptor FcRn large subunit p51: A
Beta-2-microglobulin: B
1519.g57- Light chain: C
1519.g57- Heavy chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
L

D
H

IgG receptor FcRn large subunit p51

Beta-2-microglobulin

1519.g57- Light chain

1519.g57- Heavy chain

Related Entries With Identical Sequence